CARTITUDE-2
Phase 2, Open-Label Study Evaluating the Use of an Investigational CAR-T Cell therapy in Participants with Multiple Myeloma
What's the purpose of the trial?
This trial is evaluating the safety and efficacy of an investigational CAR-T cell medication in participants with multiple myeloma.
Trial status
Active, Not Recruiting
Phase
Phase 2
Enrollment
237
Last Updated
1 day ago
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.